A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 04 Jun 2019
Price : $35 *
At a glance
- Drugs Clofarabine (Primary) ; Mitoxantrone (Primary) ; Cytarabine; Dexrazoxane; Rituximab
- Indications Acute myeloid leukaemia; Burkitt's lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Acronyms MITCL
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 11 Mar 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 11 Mar 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.